PRO133 ASSOCIATION BETWEEN HEALTH-RELATED QUALITY OF LIFE AND PULMONARY ARTERIAL HYPERTENSION (PAH) DISEASE SEVERITY: A REVIEW OF GRIPHON, SERAPHIN, COMPASS-2 AND EARLY TRIALS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2462
https://www.valueinhealthjournal.com/article/S1098-3015(19)34840-5/fulltext
Title :
PRO133 ASSOCIATION BETWEEN HEALTH-RELATED QUALITY OF LIFE AND PULMONARY ARTERIAL HYPERTENSION (PAH) DISEASE SEVERITY: A REVIEW OF GRIPHON, SERAPHIN, COMPASS-2 AND EARLY TRIALS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34840-5&doi=10.1016/j.jval.2019.09.2462
First page :
Section Title :
Open access? :
No
Section Order :
12151